Skip to main content
Premium Trial:

Request an Annual Quote

Sanford Health, Children's Hospitals Form Genomic Medicine Consortium

NEW YORK (GenomeWeb) – Sanford Health announced today the formation of the Sanford Children's Genomic Medicine Consortium, a network of six children's hospitals that will collaborate to advance personalized medicine in pediatric healthcare.

Members of the consortium include Sanford Children's; Children's Hospital Los Angeles; Rady Children's Hospital, San Diego; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota; and Banner Children's at Diamond Children's Medical Center in Tucson.

"This groundbreaking collaboration among premier children's hospitals and leaders in genomic and pediatric care will help set the standard for sharing resources and collaborating in research and education in personalized medicine for children," Sanford Health's Gene Hoyme, medical director of the consortium, said in a statement.

According to Sanford Health, consortium members will undertake joint research programs and genomic healthcare workforce development efforts, and combine research capabilities to facilitate genetic and genomic discovery. The consortium itself is expected to serve as a focal point for developing relationships between industry and government agencies, and provide shared training opportunities for physicians, genetic counselors, nurses, and other health professionals.

The consortium has also established an external scientific advisory board to help guide its overall scientific direction. Members of the advisory board include representatives from the American Academy of Pediatrics, the American College of Medical Genetics and Genomics, and the National Human Genome Research.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.